Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Real Pandemic World Results of Personalized Prophylaxis of Bleeds in Polish Children and Adolescents with Severe Hemophilia a

Blood (2022) 140 (Supplement 1): 2737–2739.

https://doi.org/10.1182/blood-2022-162204

Published: 2022

Journal Articles

Polymorphic Variant in GATA3 gene Is a Hallmark of PAR1-Deleted BCP-ALL and Associates with Poor Prognosis Among Pediatric Patients Treated with the BFM Backbone Protocols

Joanna Madzio, MSc, Agata Pastorczak, MDPhD, Marcin Braun, MD, Joanna Taha, PhD, Kamila Wypyszczak, MSc, Michal Matysiak, Prof., MD PhD, Jerzy Kowalczyk, Prof MD PhD, Wanda Badowska, MD PhD, Jan Styczynski, MD PhD, Joanna Trelińska, MD Ph, Bernarda Kazanowska, MD PhD, Nina Irga-Jaworska, MD PhD, Katarzyna Derwich, MD PhD, Monika Lejman, PhD, Wojciech Fendler, Assoc Prof MD PhD, Edyta Ulinska, MD, Lukasz Sedek, MD PhD, Tomasz Szczepanski, Prof MD PhD, Wojciech Mlynarski, Prof MD PhD

Blood (2016) 128 (22): 1742.

https://doi.org/10.1182/blood.V128.22.1742.1742

Published: 2016

Journal Articles

Differential in Vitro Drug Resistance Profile Between First and Second Relapsed Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia in Children

Blood (2015) 126 (23): 3696.

https://doi.org/10.1182/blood.V126.23.3696.3696

Published: 2015

Journal Articles

Infectious Complications in Children with ALL Treated with ALL-IC-2009 Protocol: Multicenter National Study of Polish Society of Pediatric Hematology and Oncology

Blood (2014) 124 (21): 5247.

https://doi.org/10.1182/blood.V124.21.5247.5247

Published: 2014

Journal Articles

Surface Expression of CRLF2 Protein Is Associated with Lower Minimal Residual Disease (MRD) Among Children with IKZF1- deleted Acute Lymphoblastic Leukemia (ALL)

Agata Pastorczak, MDPhD, Lukasz Sedek, PhD, Marcin Braun, MD, Joanna Madzio, MSc, Alicja Sonsala, MSc, Marta Bielska, MSc, Joanna Taha, PhD, Patryk Gorniak, PhD, Edyta Ulinska, MD, Michal Matysiak, MD PhD, Katarzyna Derwich, MDPhD, Monika Lejman, PhD, Jerzy Kowalczyk, MDPhD, Wanda Badowska, MDPhD, Maciej Niedzwiecki, MD, Bernarda Kazanowska, MDPhD, Tomasz Szczepanski, MD PhD, Wojciech Mlynarski, MDPhD

Blood (2014) 124 (21): 2400.

https://doi.org/10.1182/blood.V124.21.2400.2400

Published: 2014

Journal Articles

Heterogeneity Of CXCR4 Expression In Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Tomasz Szczepanski, MD, PHD, Urszula Malek, Lukasz Sedek, PhD, Alicja Sonsala, Joanna Zawitkowska, Teresa Odoj, Iwona Malinowska, MD, PhD, Joanna Trelinska, Ewa Niedzielska, Katarzyna Derwich, Wanda Badowska, MD, PhD, Maciej Niedzwiecki, Grazyna Sobol-Milejska, Katarzyna Muszynska-Roslan, Mariusz Wysocki, MD, PhD, Grazyna Karolczyk, MD, Maria Wieczorek, Tomasz Urasinski, MD PhD, Jerzy R Kowalczyk

Blood (2013) 122 (21): 4652.

https://doi.org/10.1182/blood.V122.21.4652.4652

Published: 2013

Journal Articles

Heterogeneity Of CXCR4 Expression In Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Blood (2013) 122 (21): 4952.

https://doi.org/10.1182/blood.V122.21.4952.4952

Published: 2013

Journal Articles

Individualized Tumor Response Testing (ITRT) Profile Has a Prognostic Value in Childhood Acute Lymphoblastic Leukemia (ALL) and Acute Non-Lymphoblastic Leukemia (ANLL): The Multicenter Non-Interventional Long-Term Follow-up Study of Polish Pediatric Leukemia Study Group

Blood (2011) 118 (21): 1456.

https://doi.org/10.1182/blood.V118.21.1456.1456

Published: 2011

Journal Articles

Prognostic Impact of Combined Ex Vivo Drug Resistance to Fludarabine, Treosulphan and Mitoxantrone in Childhood Acute Myeloid Leukemia.

Blood (2005) 106 (11): 2780.

https://doi.org/10.1182/blood.V106.11.2780.2780

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real Pandemic World Results of Personalized Prophylaxis of Bleeds in Polish Children and Adolescents with Severe Hemophilia a

Polymorphic Variant in GATA3 gene Is a Hallmark of PAR1-Deleted BCP-ALL and Associates with Poor Prognosis Among Pediatric Patients Treated with the BFM Backbone Protocols

Differential in Vitro Drug Resistance Profile Between First and Second Relapsed Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia in Children

Infectious Complications in Children with ALL Treated with ALL-IC-2009 Protocol: Multicenter National Study of Polish Society of Pediatric Hematology and Oncology

Surface Expression of CRLF2 Protein Is Associated with Lower Minimal Residual Disease (MRD) Among Children with IKZF1- deleted Acute Lymphoblastic Leukemia (ALL)

Heterogeneity Of CXCR4 Expression In Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Heterogeneity Of CXCR4 Expression In Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Individualized Tumor Response Testing (ITRT) Profile Has a Prognostic Value in Childhood Acute Lymphoblastic Leukemia (ALL) and Acute Non-Lymphoblastic Leukemia (ANLL): The Multicenter Non-Interventional Long-Term Follow-up Study of Polish Pediatric Leukemia Study Group

Prognostic Impact of Combined Ex Vivo Drug Resistance to Fludarabine, Treosulphan and Mitoxantrone in Childhood Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only